通过AhR介导的SPARC/FILIP1L信号传输,TDO2促进了膀癌的进展
Xiaoju Ding1, Yunjie Jin2, Xiaokai Shi3
1Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Biochemical pharmacology
|March 29, 2024
概括
二二氧化酶 (TDO2) 在膀癌中升高,促进瘤生长和对西斯普拉丁的耐药性. 抑制TDO2为膀癌管理提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 二二氧化酶 (TDO2) 与各种癌症有关.
- 它在膀癌进展中的作用尚不清楚.
- 了解TDO2的功能对于膀癌治疗至关重要.
研究的目的:
- 研究TDO2在膀癌中的作用.
- 为了确定TDO2的预后意义和功能影响.
- 探索TDO2在膀癌中的治疗潜力.
主要方法:
- 在膀癌组织中分析TDO2表达.
- 功能性测试评估细胞增殖和转移.
- 涉及酸受体 (AhR) 信号的机制研究.
- 使用TDO2抑制剂 (680C91) 的体内研究.
主要成果:
- 在膀癌中,TDO2的表达上调,预示着生存率较低.
- TDO2增强了扩散,转移和对西斯普拉丁的耐药性.
- 通过 AhR 信号,TDO2 通过 AhR 信号升级调节 SPARC 和 FILIP1L.
- TDO2与基底/状膀癌亚型相关,并由RB1和TP53.3调节.
结论:
- TDO2是膀癌进展的重要驱动因素.
- 用680C91准TDO2可以抑制瘤生长和转移.
- 抑制TDO2增强了西斯的疗效,为膀癌提供了一种新的治疗方法.
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


